172 related articles for article (PubMed ID: 25338303)
1. E4BP4 is a repressor of epigenetically regulated SOSTDC1 expression in breast cancer cells.
Rawat A; Gopisetty G; Thangarajan R
Cell Oncol (Dordr); 2014 Dec; 37(6):409-19. PubMed ID: 25338303
[TBL] [Abstract][Full Text] [Related]
2. E4BP4 promotes thyroid cancer proliferation by modulating iron homeostasis through repression of hepcidin.
Zhou Q; Chen J; Feng J; Wang J
Cell Death Dis; 2018 Sep; 9(10):987. PubMed ID: 30250199
[TBL] [Abstract][Full Text] [Related]
3. E4BP4/NFIL3 modulates the epigenetically repressed RAS effector RASSF8 function through histone methyltransferases.
Karthik IP; Desai P; Sukumar S; Dimitrijevic A; Rajalingam K; Mahalingam S
J Biol Chem; 2018 Apr; 293(15):5624-5635. PubMed ID: 29467226
[TBL] [Abstract][Full Text] [Related]
4. SOSTDC1 down-regulation of expression involves CpG methylation and is a potential prognostic marker in gastric cancer.
Gopal G; Raja UM; Shirley S; Rajalekshmi KR; Rajkumar T
Cancer Genet; 2013 May; 206(5):174-82. PubMed ID: 23830730
[TBL] [Abstract][Full Text] [Related]
5. DNA methylation of claudin-6 promotes breast cancer cell migration and invasion by recruiting MeCP2 and deacetylating H3Ac and H4Ac.
Liu Y; Jin X; Li Y; Ruan Y; Lu Y; Yang M; Lin D; Song P; Guo Y; Zhao S; Dong B; Xie Y; Dang Q; Quan C
J Exp Clin Cancer Res; 2016 Jul; 35(1):120. PubMed ID: 27461117
[TBL] [Abstract][Full Text] [Related]
6. SOSTDC1 differentially modulates Smad and beta-catenin activation and is down-regulated in breast cancer.
Clausen KA; Blish KR; Birse CE; Triplette MA; Kute TE; Russell GB; D'Agostino RB; Miller LD; Torti FM; Torti SV
Breast Cancer Res Treat; 2011 Oct; 129(3):737-46. PubMed ID: 21113658
[TBL] [Abstract][Full Text] [Related]
7. Caspase 8 and maspin are downregulated in breast cancer cells due to CpG site promoter methylation.
Wu Y; Alvarez M; Slamon DJ; Koeffler P; Vadgama JV
BMC Cancer; 2010 Feb; 10():32. PubMed ID: 20132554
[TBL] [Abstract][Full Text] [Related]
8. Recruitment of histone methyltransferase G9a mediates transcriptional repression of Fgf21 gene by E4BP4 protein.
Tong X; Zhang D; Buelow K; Guha A; Arthurs B; Brady HJ; Yin L
J Biol Chem; 2013 Feb; 288(8):5417-25. PubMed ID: 23283977
[TBL] [Abstract][Full Text] [Related]
9. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
[TBL] [Abstract][Full Text] [Related]
10. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.
Veeck J; Noetzel E; Bektas N; Jost E; Hartmann A; Knüchel R; Dahl E
Mol Cancer; 2008 Nov; 7():83. PubMed ID: 18990230
[TBL] [Abstract][Full Text] [Related]
11. XAF1 is frequently methylated in human esophageal cancer.
Chen XY; He QY; Guo MZ
World J Gastroenterol; 2012 Jun; 18(22):2844-9. PubMed ID: 22719195
[TBL] [Abstract][Full Text] [Related]
12. ALX4, an epigenetically down regulated tumor suppressor, inhibits breast cancer progression by interfering Wnt/β-catenin pathway.
Yang J; Han F; Liu W; Chen H; Hao X; Jiang X; Yin L; Huang Y; Cao J; Zhang H; Liu J
J Exp Clin Cancer Res; 2017 Nov; 36(1):170. PubMed ID: 29183346
[TBL] [Abstract][Full Text] [Related]
13. Frequent epigenetic inactivation of Wnt inhibitory factor-1 in human gastrointestinal cancers.
Taniguchi H; Yamamoto H; Hirata T; Miyamoto N; Oki M; Nosho K; Adachi Y; Endo T; Imai K; Shinomura Y
Oncogene; 2005 Nov; 24(53):7946-52. PubMed ID: 16007117
[TBL] [Abstract][Full Text] [Related]
14. PTHrP(1-34)-mediated repression of the PHEX gene in osteoblastic cells involves the transcriptional repressor E4BP4.
Pellicelli M; Taheri M; St-Louis M; Bériault V; Desgroseillers L; Boileau G; Moreau A
J Cell Physiol; 2012 Jun; 227(6):2378-87. PubMed ID: 21826652
[TBL] [Abstract][Full Text] [Related]
15. The role of PAQR3 gene promoter hypermethylation in breast cancer and prognosis.
Chen J; Wang F; Xu J; He Z; Lu Y; Wang Z
Oncol Rep; 2016 Sep; 36(3):1612-8. PubMed ID: 27461225
[TBL] [Abstract][Full Text] [Related]
16. ECRG4 acts as a tumor suppressor gene frequently hypermethylated in human breast cancer.
Tang GY; Tang GJ; Yin L; Chao C; Zhou R; Ren GP; Chen JY; Zhang W
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30918105
[TBL] [Abstract][Full Text] [Related]
17. Demethylation by 5-aza-2'-deoxycytidine in colorectal cancer cells targets genomic DNA whilst promoter CpG island methylation persists.
Mossman D; Kim KT; Scott RJ
BMC Cancer; 2010 Jul; 10():366. PubMed ID: 20618997
[TBL] [Abstract][Full Text] [Related]
18. A novel E4BP4 element drives circadian expression of mPeriod2.
Ohno T; Onishi Y; Ishida N
Nucleic Acids Res; 2007; 35(2):648-55. PubMed ID: 17182630
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic silencing of glutaminase 2 in human liver and colon cancers.
Zhang J; Wang C; Chen M; Cao J; Zhong Y; Chen L; Shen HM; Xia D
BMC Cancer; 2013 Dec; 13():601. PubMed ID: 24330717
[TBL] [Abstract][Full Text] [Related]
20. The TCF4/β-catenin pathway and chromatin structure cooperate to regulate D-glucuronyl C5-epimerase expression in breast cancer.
Mostovich LA; Prudnikova TY; Kondratov AG; Gubanova NV; Kharchenko OA; Kutsenko OS; Vavilov PV; Haraldson K; Kashuba VI; Ernberg I; Zabarovsky ER; Grigorieva EV
Epigenetics; 2012 Aug; 7(8):930-9. PubMed ID: 22805760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
